310 related articles for article (PubMed ID: 25540985)
1. Rapid cytometric antibiotic susceptibility testing utilizing adaptive multidimensional statistical metrics.
Huang TH; Ning X; Wang X; Murthy N; Tzeng YL; Dickson RM
Anal Chem; 2015 Feb; 87(3):1941-9. PubMed ID: 25540985
[TBL] [Abstract][Full Text] [Related]
2. Probing minority population of antibiotic-resistant bacteria.
Huang T; Zheng Y; Yan Y; Yang L; Yao Y; Zheng J; Wu L; Wang X; Chen Y; Xing J; Yan X
Biosens Bioelectron; 2016 Jun; 80():323-330. PubMed ID: 26852201
[TBL] [Abstract][Full Text] [Related]
3. MICy: a Novel Flow Cytometric Method for Rapid Determination of Minimal Inhibitory Concentration.
Kállai A; Kelemen M; Molnár N; Tropotei A; Hauser B; Iványi Z; Gál J; Ligeti E; Kristóf K; Lőrincz ÁM
Microbiol Spectr; 2021 Dec; 9(3):e0090121. PubMed ID: 34878335
[TBL] [Abstract][Full Text] [Related]
4. [Evolution of susceptibility to antibiotics of Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumanii, in a University Hospital Center of Beirut between 2005 and 2009].
Hamouche E; Sarkis DK
Pathol Biol (Paris); 2012 Jun; 60(3):e15-20. PubMed ID: 21719212
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity and pharmacodynamics of commonly used antibiotics against adult systemic isolates of Escherichia coli and Pseudomonas aeruginosa at Forty US Hospitals.
Eagye KJ; Kuti JL; Sutherland CA; Christensen H; Nicolau DP
Clin Ther; 2009 Nov; 31(11):2678-88. PubMed ID: 20110010
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Escherichia coli viability by flow cytometry: A method for determining bacterial responses to antibiotic exposure.
Boi P; Manti A; Pianetti A; Sabatini L; Sisti D; Rocchi MB; Bruscolini F; Galluzzi L; Papa S
Cytometry B Clin Cytom; 2015; 88(3):149-53. PubMed ID: 25532721
[TBL] [Abstract][Full Text] [Related]
7. Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia.
Perez KK; Olsen RJ; Musick WL; Cernoch PL; Davis JR; Peterson LE; Musser JM
J Infect; 2014 Sep; 69(3):216-25. PubMed ID: 24841135
[TBL] [Abstract][Full Text] [Related]
8. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
[TBL] [Abstract][Full Text] [Related]
9. Rapid discrimination of bacterial species with different ampicillin susceptibility levels by means of flow cytometry.
Walberg M; Gaustad P; Steen HB
Cytometry; 1997 Nov; 29(3):267-72. PubMed ID: 9389444
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial resistance in Escherichia coli and Pseudomonas aeruginosa from Intensive Care Units in The Netherlands, 1998-2005.
Oudhuis GJ; Verbon A; Hoogkamp-Korstanje JA; Stobberingh EE;
Int J Antimicrob Agents; 2008 Jan; 31(1):58-63. PubMed ID: 17961989
[TBL] [Abstract][Full Text] [Related]
11. Continuous administration of PBP-2- and PBP-3-specific beta-lactams causes higher cytokine responses in murine Pseudomonas aeruginosa and Escherichia coli sepsis.
Buijs J; Dofferhoff AS; Mouton JW; van der Meer JW
J Antimicrob Chemother; 2007 May; 59(5):926-33. PubMed ID: 17395686
[TBL] [Abstract][Full Text] [Related]
12. Isolation of an amikacin-resistant Escherichia coli strain after tobramycin treatment of previous recurrent episodes of respiratory tract infections caused by Pseudomonas aeruginosa.
Ruiz J; Bertran S; Sauca G; Julià A; Vila X; Gómez E; Jiménez de Anta MT; Vila J
Clin Microbiol Infect; 2005 Jan; 11(1):71-3. PubMed ID: 15649309
[TBL] [Abstract][Full Text] [Related]
13. Fluorescence monitoring of antibiotic-induced bacterial damage using flow cytometry.
Suller MT; Lloyd D
Cytometry; 1999 Mar; 35(3):235-41. PubMed ID: 10082304
[TBL] [Abstract][Full Text] [Related]
14. Unchanged antibiotic susceptibility in Escherichia coli and Pseudomonas aeruginosa after long-term in vitro exposure to antineoplastic drugs.
Kvakkestad KM; Gammelsrud KW; Brandtzaeg P; Høiby EA
Chemotherapy; 2012; 58(2):118-22. PubMed ID: 22507969
[TBL] [Abstract][Full Text] [Related]
15. Bacterial antibiotic resistance studies using in vitro dynamic models: Population analysis vs. susceptibility testing as endpoints of mutant enrichment.
Firsov AA; Strukova EN; Portnoy YA; Shlykova DS; Zinner SH
Int J Antimicrob Agents; 2015 Sep; 46(3):313-8. PubMed ID: 26297633
[TBL] [Abstract][Full Text] [Related]
16. Serum bactericidal activity of piperacillin/tazobactam against Staphylococcus aureus, piperacillin-susceptible and piperacillin-resistant Escherichia coli and Pseudomonas aeruginosa.
Lemmen SW; Zolldann D; Klik S; Lütticken R; Kümmerer K; Häfner H
Chemotherapy; 2004 Apr; 50(1):27-30. PubMed ID: 15084802
[TBL] [Abstract][Full Text] [Related]
17. Associated antimicrobial resistance in Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae and Streptococcus pyogenes.
Wimmerstedt A; Kahlmeter G
Clin Microbiol Infect; 2008 Apr; 14(4):315-21. PubMed ID: 18261127
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of antibiotic efficacy against infections caused by planktonic or biofilm cultures of Pseudomonas aeruginosa and Klebsiella pneumoniae in Galleria mellonella.
Benthall G; Touzel RE; Hind CK; Titball RW; Sutton JM; Thomas RJ; Wand ME
Int J Antimicrob Agents; 2015 Nov; 46(5):538-45. PubMed ID: 26364845
[TBL] [Abstract][Full Text] [Related]
19. Pharmacodynamics of polymyxin B against Pseudomonas aeruginosa.
Tam VH; Schilling AN; Vo G; Kabbara S; Kwa AL; Wiederhold NP; Lewis RE
Antimicrob Agents Chemother; 2005 Sep; 49(9):3624-30. PubMed ID: 16127031
[TBL] [Abstract][Full Text] [Related]
20. Significance of fluoroquinolone-resistant Escherichia coli in urinary tract infections.
Shigemura K; Arakawa S; Miura T; Nakano Y; Tanaka K; Fujisawa M
Jpn J Infect Dis; 2008 May; 61(3):226-8. PubMed ID: 18503177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
